Table 1.
Total no = 247 | No (%) 1 |
---|---|
Demographic information | |
Age, median (IQR) | 40.0 (30–52) |
Sex | |
Female | 116 (58.0) |
Male | 84 (42.0) |
Comorbidities | |
Cardiovascular disease | 39 (15.8) |
Hypertension | 36 (14.6) |
Coronary artery disease | 17 (6.9) |
Congestive heart failure | 5 (2.0) |
Malignancy | 21 (8.5) |
Diabetes mellitus | 19 (7.7) |
Chronic obstructive pulmonary disease (COPD) | 13 (5.3) |
Chronic renal disease | 4 (1.6) |
Active smoker | 65 (26.3) |
At least one comorbid disease | 73 (29.6) |
At least two comorbid diseases | 29 (11.7) |
Medications | |
Anti-hypertensives | 34 (13.8) |
Angiotensin-converting enzyme (ACE) inhibitors | 16 (6.5) |
Angiotensin receptor blockers (ARB) | 11 (4.5) |
Others (beta-blocker, calcium channel blocker) | 10 (4.0) |
Statins | 7 (3.5) |
NSAI drugs | 5 (2.0) |
Steroids | 9 (3.6) |
Immunosuppressive agents | 18 (7.3) |
Distribution of cases | |
Confirmed cases | 175 (70.9) |
Clinically diagnosed cases | 72 (29.1) |
1 Percentages are calculated on the total number of patients.